Placebo (0.9% NaCl) Clinical Trials
2 recruitingDevice
Phase 31Not Applicable1
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Acute Kidney Injury
Talphera, Inc70 enrolled10 locationsNCT06150742
Recruiting
Phase 3
Canakinumab for the Treatment of Postprandial Hypoglycemia
Postprandial Hypoglycemia
University Hospital, Basel, Switzerland56 enrolled2 locationsNCT05401578